Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

431 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI).
Prakash N, Caspell-Garcia C, Coffey C, Siderowf A, Tanner CM, Kieburtz K, Mollenhauer B, Galasko D, Merchant K, Foroud T, Chahine LM, Weintraub D, Casaceli C, Dorsey R, Wilson R, Herzog M, Daegele N, Arnedo V, Frasier M, Sherer T, Marek K, Frank S, Jennings D, Simuni T; Parkinson's Progression Markers InitiativeSteering Committee; Study Cores; Site Investigators; Coordinators; Industry and Scientific Advisory Board. Prakash N, et al. Parkinsonism Relat Disord. 2019 May;62:201-209. doi: 10.1016/j.parkreldis.2018.12.025. Epub 2019 Jan 31. Parkinsonism Relat Disord. 2019. PMID: 30738748 Free PMC article.
Infusion Therapies for Parkinson's Disease.
Prakash N, Simuni T. Prakash N, et al. Curr Neurol Neurosci Rep. 2020 Aug 1;20(9):44. doi: 10.1007/s11910-020-01062-2. Curr Neurol Neurosci Rep. 2020. PMID: 32740768 Review.
CLINICAL TRIAL HIGHLIGHTS - DYSKINESIA.
McFarthing K, Prakash N, Simuni T. McFarthing K, et al. Among authors: prakash n. J Parkinsons Dis. 2019;9(3):449-465. doi: 10.3233/JPD-199002. J Parkinsons Dis. 2019. PMID: 31356217 Free PMC article. Review. No abstract available.
Clinical Trial Highlights - Kinase Inhibitors.
Prakash N, McFarthing K, Simuni T. Prakash N, et al. J Parkinsons Dis. 2021;11(2):377-390. doi: 10.3233/JPD-219003. J Parkinsons Dis. 2021. PMID: 33749620 Clinical Trial. No abstract available.
Phase 3 in Focus - Ampreloxetine, Theravance Biopharma.
McFarthing K, Prakash N, Simuni T. McFarthing K, et al. Among authors: prakash n. J Parkinsons Dis. 2021;11(2):391-393. doi: 10.3233/JPD-219004. J Parkinsons Dis. 2021. PMID: 33749621 Clinical Trial. No abstract available.
[No title available]
[No authors listed] [No authors listed] PMID: 34957951
Clinical Trial Highlights - Infusion Therapies.
Prakash N, McFarthing K, Simuni T. Prakash N, et al. J Parkinsons Dis. 2020;10(1):5-17. doi: 10.3233/JPD-199005. J Parkinsons Dis. 2020. PMID: 31903996 Free PMC article. No abstract available.
431 results